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A B S T R A C T   
A bioassay-guided phytochemical investigation of propolis samples from Tanzania and Zambia that screened for 
activity against Trypanosoma brucei has led to the isolation of two novel flavanones with promising anti-
trypanosomal activity. The compounds were characterized based on their spectral and physical data and iden-
tified as 6-(1,1-dimethylallyl) pinocembrin and 5-hydroxy-4′′,4′′-dimethyl-5′′-methyl-5′′-H-dihydrofuranol 
[2′′,3′′,6,7] flavanone. The two compounds, together with the propolis extracts and fractions, were assayed 
against a standard drug-sensitive strain of T. b. brucei (s427 wild-type), multi-drug resistant-resistant T. b. brucei 
(B48), drug-sensitive T. congolense (1L300) and a derived diminazene-resistant T. congolense strain (6C3), and for 
toxicity against U947 human cells and RAW 246.7 murine cells. Activity against T. b. brucei was higher than 
against T. congolense. Interestingly, the Tanzanian propolis extract was found to be more active than its fractions 
and purified compounds in these assays, with an IC50 of 1.20 μg/mL against T. b. brucei. The results of a cyto-
toxicity assay showed that the propolis extracts were less toxic than the purified compounds with mean IC50 
values > 165.0 μg/mL.   
1. Introduction 
Propolis or ‘bee glue’ is a sticky resinous substance, produced by 
honeybees to seal holes in their hives. This maintains a healthy envi-
ronment in the hive and protects them from microbes and infections 
(Ghisalberti 1979). The biological activities of propolis have been 
well-studied and reported in the literature. Previously, 22 propolis 
samples from nine sub-Saharan African countries including Zambia and 
Tanzania, were profiled using high resolution LC-MS, GC-MS and HPLC 
and were observed to have a high degree of diversity in chemical 
composition. However, there was no clear geographic discrimination 
between the samples (Zhang et al., 2014). It has also been reported that a 
Tanzanian propolis extract showed greater antibacterial activity against 
a range of gram positive bacteria than a Zambian propolis extract (Seidel 
et al., 2008). However, there is still a lack of information on propolis 
from Zambia and Tanzania, particularly the bioactivity of isolated 
compounds from these samples. In this study, a bioassay guided tech-
nique has been used to identify some active metabolites from these 
samples using in vitro assays against Trypanosoma brucei, drug-resistant 
T. b. brucei, T. congolense, and drug-resistant T. congolense. The subspe-
cies of T. b. brucei, T. b. gambiense and T. b. rhodesiense, cause sleeping 
sickness, or Human African Trypanosomiasis (HAT) in humans (De 
Koning 2020) and T. b. brucei and T. congolense cause a severe disease in 
animals, called nagana, or African Animal Trypanosomiasis (AAT)) 
(Giordani et al., 2016). There is increasing evidence that bees produce 
propolis to protect their hives against protozoal infections (Alotaibi 
et al., 2019). The in vitro cytotoxicity of the samples was also evaluated 
against human U937 cells and murine RAW 246.7 cells. 
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2. Materials and methods 
2.1. General 
The Zambian propolis sample was provided by Forest Fruits Co 
Lusaka and originated from North West Zambia, while the Tanzanian 
propolis sample was obtained from the area around the city of Moshi in 
Northern Tanzania. Solvents, reagents and other consumables were 
purchased from Sigma-Aldrich, Fisher Scientific, Bio-Wittaker or Merck 
UK. Column chromatography was carried out using silica gel 60 of 
particle size 0.063–0.200 mm. A UNICAM UV 300 spectrophotometer 
was used to determine the UV–Vis absorption spectra of the compounds 
in the range from 190 to 750 nm. The IR spectra of isolated compounds 
were recorded on a PerkinElmer Fourier transform infrared (FT-IR, 
model 1725X) with an attenuated total reflection (ATR) probe in the 
region 400 to 4000 cm−1. Melting points were determined using a Stuart 
Scientific melting point apparatus (Bibby, UK). NMR spectra were ob-
tained on a Bruker AV3HD500 spectrophotometer using CDCl3 or 
DMSO‑d6 as solvents. NMR spectra were processed using Mnova (Mes-
trelab Research, Santiago de Compostela, Spain). 
2.2. Extraction and fractionation 
About 8.2 g of the Zambian propolis sample was extracted three 
times for 1 h, with 150 mL of ethanol at room temperature, under 
sonication (Clifton ultrasonic bath, Fisher Scientific, Loughborough, UK) 
yielding 6.48 g of extract. The extracts were combined, the solvent was 
evaporated using a rotary evaporator (Buchi, VWR, Leicestershire, UK), 
and the residue was weighed. 7.7 g of the Tanzanian propolis sample 
was extracted consecutively with solvents of increasing polarity starting 
with n-hexane, followed by ethyl acetate and methanol and the extracts 
were finally combined to yield a total extract weight of 3.4 g. It was 
hoped that the consecutive solvent extraction method might give better 
recovery but this was apparently not the case. Recovery of residues and 
re-extraction with the solvent was carried out using sonication. The 
extracts were filtered and concentrated under vacuum using a Buchi 
rotary evaporator. Fractionation of the extracts was carried out as 
described in Section S1 (Supplementary information). 
2.3. LC and LC-MS analysis 
All profiled samples and fractions were dissolved in methanol to give 
a concentration of 1 mg/mL. LC-MS analysis was carried out on an 
Accela 600 HPLC system combined with an Exactive (Orbitrap) mass 
spectrometer from (ThermoFisher, Hemel Hempstead, UK). MS detec-
tion range was from 100 to 1200 m/z and the scanning was performed 
under electrospray ionization polarity switching mode. The needle 
voltages were set at −4.0 kV (negative) and 4.5 kV (positive); and sheath 
and auxiliary gases were at 50 and 17 arbitrary units respectively. 
Separation was performed on an ACE C18 column (Hichrom Reading 
UK, 150 × 3 mm, 3 μm) with 0.1% v/v formic acid in water as mobile 
phase A and 0.1% v/v formic acid in acetonitrile as B at a flow rate of 
0.3 mL/min, using the following gradient: 25% B for 30 min, 5 min 
100% B, and 5 min 25% B, injecting 10 μL of sample solution. The MS2 
spectra were obtained on an LTQ Orbitrap Fourier Transform Mass 
Spectrometer (FTMS) under the same conditions described for the 
Exactive instrument, with a collision energy of 35 V, and data were 
processed using Xcalibur software. 
2.4. Determination of cytotoxic effect on U937 and RAW 246.7 
mammalian cell lines 
The U937 cells (a human cell line from the European Collection of 
Cell Cultures Cat. No. 85011440, supplied by Sigma-Aldrich, Dorset, 
UK) were cultured as described in RPMI 1640 medium (Lonza) supple-
mented with 5% FBS, 1% L-Glutamine and 1% Penicillin/Streptomycin 
at 37 ◦C in a humidified atmosphere of 5% CO2 as previously described 
(Passmore et al., 2001). RAW 264.7 (ATCC-TIB-71), a murine macro-
phage cell line, was cultured in Dulbecco’s Modified Eagle’s Medium 
(DMEM; ATCC, Catalogue No. 30–2002) supplemented with the 
following additions: 10% fetal bovine serum (FBS) (Biosera), 1% (v/v) 
each of 2 mM L-glutamine (Life Technologies, Paisley, UK) and 100 
IU/100 μg/mL penicillin/streptomycin (Life Technologies, Paisley, UK). 
The cytotoxicity assay method with RAW246.7 and the cell density 
determinations were carried out as described by Han et al. (2002) (Han 
et al., 2002). U937 cells were grown to log phase at 37 ◦C and harvested 
at a density of 1 × 105 cells/ml in a 96-well plate (TPP, Switzerland). 
100 μl of the cell suspension was added to each well and the plate was 
incubated for 24 h at 37 ◦C, 5% CO2, 100% humidity. In order to 
determine the EC50 value for each sample, a 2-fold serial dilution of the 
test compound was carried out in a separate 96-well plate, using the 
appropriate culture medium, and 100 μl of each dilution was then 
transferred to the cultured cells using a multichannel pipette, followed 
by another incubation for 24 h. To each well 20 μL of 5 mM resazurin 
sodium salt (Sigma-Aldrich) was added and the plates were incubated 
for a further 24 h, after which fluorescence was measured using a Wallac 
Victor 2 microplate reader (λ Ex/Em: 560/590 nm). The compound was 
tested in triplicate and cell viability was expressed as a percentage of the 
drug-free control. The resulting data were analyzed using GraphPad 
Prism 8 to obtain dose-response curves and corresponding 50% inhibi-
tory concentration (IC50) values. 
2.5. Trypanosoma strains and cultures, and anti-trypanosomal assay 
Pairs of standard drug-sensitive laboratory strains and derived clonal 
lines made resistant to first-line drugs by in vitro exposure were used to 
assess general efficacy of propolis samples and isolated compounds, and 
Table 1 
EC50 values of ZP and TP propolis samples and its fractions on T. brucei s427 
wild-type and B48 (n = 3).  
Samples T. brucei S427WT T. brucei B48 
EC50, AVG ± SEM (μg/ 
mL) 





Zambian propolis (ZP) and its fractions 
ZP Crudea 4.14 ± 0.12 7.39 ± 0.50 1.78 0.0032 
ZP-F1a 17.05 ± 0.75 16.66 ± 1.90 0.98 0.8557 
ZP-F2a 1.76 ± 0.06 1.95 ± 0.15 1.11 0.2976 
ZP-F3a 0.94 ± 0.06 1.50 ± 0.13 1.59 0.0165 
ZP-F4a 1.10 ± 0.03 0.97 ± 0.05 0.89 0.0821 
ZP-F5a 1.23 ± 0.03 1.07 ± 0.07 0.87 0.0986 
ZP-F6a 2.26 ± 0.03 2.30 ± 0.20 1.02 0.8813 
ZP-F7a 4.31 ± 0.17 4.36 ± 0.28 1.01 0.8733 
ZP-F8a 5.41 ± 0.15 6.10 ± 0.27 1.13 0.1761 
ZP-F9a 7.75 ± 0.35 7.46 ± 0.48 0.96 0.6509 
Tanzanian propolis (ZP) and its fractions 
TP crudea 1.20 ± 0.04 1.02 ± 0.07 0.85 0.0843 
TP-F1a 5.78 ± 0.44 6.07 ± 0.67 1.05 0.7392 
TP-F2a 8.76 ± 0.44 8.54 ± 0.65 0.98 0.8001 
TP-F3a 4.87 ± 0.21 5.78 ± 0.61 1.19 0.2272 
TP-F4a 2.36 ± 0.18 2.58 ± 0.33 1.10 0.5751 
TP-F5a 4.23 ± 0.21 5.45 ± 0.41 1.29 0.0565 
TP-F6a 15.78 ± 0.74 16.84 ± 1.26 1.07 0.5110 
TP-F7a 4.45 ± 0.36 6.04 ± 0.66 1.36 0.1021 
TP-F8a 8.23 ± 0.48 7.82 ± 1.38 0.95 0.7936 




Pentamidineb 0.0031 ± 0.0003 0.4816 ± 0.02 157.84 <0.0001 
The EC50 values are the average ± SEM of at least 3 independent de-
terminations. a EC50 in μg/mL; b EC50 in μM. RF = Resistance factor, being 
EC50(WT)/EC50(B48). Statistical significance was determined using an unpaired 
two-tailed Student’s t-test comparing the EC50 values of the resistant strain with 
those obtained for the control strain s427. Pentamidine is a known trypanocide 
and used as positive control and strain control for B48 
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potential cross-resistance issues, respectively. For T. b. brucei we used 
Lister s427 WT (De Koning et al., 2000) and clone B48 (Bridges et al., 
2007), which was generated by knockout of the TbAT1 drug transporter 
(Matovu et al., 2003) followed by adaptation to high concentrations of 
pentamidine which resulted in loss of the TbAQP2 gene and high levels 
of resistance to the diamidine and melaminophenyl arsenical drugs 
(Munday et al., 2014). Culturing of T. brucei bloodstream forms was 
performed in complete HMI-9 medium with 10% fetal bovine serum at 
37 ◦C/5% CO2, as described (Gudin et al., 2006). The T. congolense 
bloodstream forms of strain IL3000 (Savannah-type), and the derived 
diminazene-resistant clone 6C3, were cultured in Minimal Essential 
Medium (MEM) base with 10% goat serum, supplemented with 14 μL/L 
β-mercapto-ethanol, glutamine and antibiotics at 34 ◦C/5% CO2 as 
described (Cerone et al., 2019). The extract and the purified compounds 
were tested against T. brucei and T. congolense using the resazurin 
viability indicator exactly as described previously (Alotaibi et al., 2019; 
Omar et al., 2017). Briefly, T. brucei (2 × 104/well) or T. congolense (5 ×
104/well) were incubated with a series of 23 doubling dilutions and 
no-drug controls in 96-well plates for 48 h prior to the addition of 
resazurin and a further incubation of 24 h. Stock solutions for each 
compound or extract concentration were prepared in DMSO, ensuring 
that there was a constant percentage of 1% (v/v) DMSO per well. 
3. Results and discussion 
3.1. In-vitro antitrypanosomal activity and cross-resistance studies of 
Zambian and Tanzanian propolis samples 
In order to determine the in vitro anti-Trypanosoma activity of the 
Zambian and Tanzanian propolis samples, the crude extracts and frac-
tions were tested against T. brucei S427WT and the multi-drug resistant 
strain B48 (Table 1). The result revealed that fraction ZP-F3 and ZP-F4 
from the Zambian propolis sample gave the best activity against 
T. brucei s427 WT in vitro (EC50 values of 0.94 and 1.10 μg/mL) 
respectively, while the most active fraction from the Tanzanian sample 
was TP-F4 (EC50 = 2.36 μg/mL). There were no significant differences in 
the EC50 values for the standard drug-sensitive strain Lister T. brucei 427 
WT and its derived resistant cell line B48 apart from ZP-F3, which 
showed a just-significant increase in its EC50 value with a resistance 
factor (RF) of 1.59, compared to an RF of 158 for pentamidine (P <
0.0001; Student’s unpaired t-test). 
The same fractions were also tested against the main AAT pathogen, 
T. congolense, and its resistant strain, finding no significant differences 
between the two strains (P > 0.05), showing that these propolis fractions 
were not cross-resistant with first-line trypanosomiasis drugs such as 
diminazene aceturate (Table 2). Interestingly, the same order of potency 
for these fractions applied for T. brucei and T. congolense, with ZP-F3 and 
ZP-F4 being the most active fractions from the Zambian propolis sample 
against T. congolense IL3000 as well (EC50 values of 5.85 and 3.92 μg/ 
mL, respectively), and TP-F4 exhibiting the most activity among Tan-
zanian fractions (EC50 = 6.34 μg/mL). Fig. 1 shows strong correlation 
between the effects against T. brucei and T. congolense, for both Zambian 
and Tanzanian fractions, but while the Zambian fractions were much 
more potent against T. brucei than against T. congolense (slope of 4.74 in 
the correlation plot; AVG of 3.85-fold), the Tanzanian propolis differ-
entiated much less between the two Trypanosoma species, indicating 
broader trypanocidal activity (slope of 1.29 in the correlation plot; AVG 
of 1.92-fold). 
Having successfully identified the most active fractions from each 
propolis sample we proceeded to purify and identify some of the active 
compounds from the selected fractions. Three new trypanocides were 
isolated. The fractionation methods are described in section S1. General 
profiling of the composition of the most active fractions from the two 
propolis samples was carried out by high resolution mass spectrometry 
and the results are presented in section S2. The elemental compositions 
of the peaks in both active fractions were consistent with most of the 
components being modified flavonoids. 
3.2. Characterization of 6-(1,1-dimethylallyl)pinocembrin (1) 
Compound 1 was obtained from the combined fractions 3 and 4 from 
open column chromatography of the ethanol extract of Zambian prop-
olis, with further purification as detailed in section S1, as a white 
crystalline solid with a melting point of 158–160 ◦C while the UV 
spectrum gave absorption maxima at λ 296 nm. The IR spectrum showed 
Table 2 
EC50 values of ZP and TP propolis fractions on T. congolense IL3000 and the 
diminazene-resistant T. congolense clone 6C3 (n = 3).  
Samples Trypanosoma congolense 
IL3000 
Trypanosoma congolense 6C3 
EC50, AVG ± SEM (μg/ 
mL) 
EC50, AVG ± SEM 
(μg/mL) 
R. F t-test 
Zambian propolis (ZP) and its fractions 
ZP Crudea 14.39 ± 0.37 13.48 ± 1.12 0.94 0.4821 
ZP-F1a 84.65 ± 4.98 76.45 ± 2.68 0.90 0.2205 
ZP-F2a 10.89 ± 0.72 14.22 ± 1.47 1.31 0.1117 
ZP-F3a 5.85 ± 0.54 5.50 ± 0.29 0.94 0.5943 
ZP-F4a 3.92 ± 0.39 4.25 ± 0.23 1.08 0.5081 
ZP-F5a 5.97 ± 0.74 8.92 ± 0.82 1.50 0.0557 
ZP-F6a 6.30 ± 0.74 6.70 ± 1.01 1.06 0.7715 
ZP-F7a 7.28 ± 0.78 8.84 ± 0.67 1.21 0.1656 
ZP-F8a 9.57 ± 0.64 9.35 ± 0.36 0.98 0.7578 
ZP-F9a 23.00 ± 1.90 23.15 ± 1.97 1.01 0.9607 
Tanzanian propolis (ZP) and its fraction 
TP crudea 1.46 ± 0.29 1.62 ± 0.27 1.11 0.7031 
TP-F1a 16.09 ± 2.32 17.55 ± 1.16 1.09 0.6045 
TP-F2a 16.32 ± 1.16 19.17 ± 0.88 1.18 0.1214 
TP-F3a 11.83 ± 1.00 12.40 ± 1.49 1.05 0.7652 
TP-F4a 6.34 ± 0.67 5.91 ± 0.60 0.93 0.6596 
TP-F5a 9.34 ± 0.58 9.63 ± 0.67 1.03 0.7613 
TP-F6a 21.34 ± 1.58 21.69 ± 0.86 1.02 0.8540 
TP-F7a 12.49 ± 1.02 15.48 ± 1.31 1.24 0.1464 
TP-F8a 8.29 ± 0.61 9.66 ± 0.89 1.17 0.2734 
TP-F9a 113.97 ± 5.55 103.03 ± 2.84 0.90 0.1544 
Control 
Diminazeneb 0.20 ± 0.03 1.51 ± 0.09 7.75 0.0002 
The EC50 values are the average ± SEM of at least 3 independent de-
terminations. a EC50 in μg/mL; b EC50 in μM. RF = Resistance factor, being 
EC50(WT)/EC50(6C3). Statistical significance was determined using an unpaired 
two-tailed Student’s t-test comparing the EC50 values of the resistant strain with 
those obtained for the control strain IL3000. Diminazene is the most used try-
panocide against AAT and used as positive control and strain control for 6C3. 
Fig. 1. Correlation plot for EC50 values of T. b. brucei and T. congolense for 
extracts of Zambian and Tanzanian propolis. The trend lines were generated by 
linear regression using Prism 8.4. Values were abstracted from Tables 1 and 2 
Error bars are SD; when not shown, fall within the symbol. 
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absorption bands at 3225 (-OH) 1720, 1700 (C–O), 1450 (C–C) cm−1, 
and 1650, 1471 cm−1 for the presence of aromatic rings. The mass 
spectrum of the compound gave an [M-H]- ion at m/z = 323.1291 (Calc 
for C20H19O4, 323.1283). The NMR spectra are shown in section S3 and 
summarized in Table 3. The most deshielded proton in its proton spec-
trum was at δH 13.13 ppm for the H-bonded 5-hydroxyl group in fla-
vonoids. The spectrum also showed a multiplet integrated for five 
protons of a mono-substituted benzene ring. The aliphatic protons at 
5.41, 3.08 and 2.84 indicated the compound is a flavanone as these 
signals are typical of the H-2, H-3a and H-3b of a flavanone moiety. The 
other aliphatic proton signals observed must be from a side chain in the 
compound. An aromatic proton singlet at 5.99 ppm indicates the side 
chain must be on ring A of the flavanone and probably at position C-6 or 
C-8. A vinyl group on the side chain was revealed by the proton signals at 
6.47 (dd, J = 17.8, 10.5 Hz), 5.38 (dd, J = 10.5, 0.9 Hz) and 5.48 (dd, J 
= 17.8, 0.9 Hz) in addition to a two methyl singlet, hence the side chain 
must be isopentyl. The 13C spectrum showed signals for a carbonyl 
carbon at δC 196.1 ppm expected for the saturated ketone of a flavanone. 
There were 12 aromatic carbon signals, five aliphatic carbons and two 
olefinic carbons at 113.4 and 149.7 ppm. The structure of the compound 
was further deduced from correlations in its 2D NMR. From the HMBC 
spectrum, the 5-OH proton showed 2J/3J correlations to C-5, C-6 and C- 
10 and the methyl protons of the side chain also showed 3J correlations 
to C-6 hence the side chain must be at position C-6. Similarly, the 7-OH 
proton showed correlations to C-6, C-7 and C-8. From the HSQC spec-
trum C-8 has the proton singlet at 5.99 ppm attached to it, thus con-
firming the substitution of the side chain at C-6 and not at C-8. The 2J/3J 
correlations, in the HMBC spectrum, from H-2 and H-3 to the carbonyl 
carbon confirm the flavanone moiety and other correlations from these 
protons to aromatic ring carbons indicate the phenyl ring is at C-2. Using 
these correlations, the chemical shifts for the protons and carbons were 
fully assigned as given in Table 3. This novel compound was 
characterized to be 6-(1,1-dimethyl allyl)pinocembrin (Fig. 2). Fig. S3-6 
shows MS2 spectrum of compound 1 at 35 V collision energy, the frag-
ments at m/z 219.07, and 245.08 are consistent with a fragment con-
taining ring A, while the fragment at m/z 267.10 consists of both rings A 
and B. A proposed fragmentation scheme is shown in Fig. S3-7. 
3.3. Characterization of 6-(1,1-Dimethylallyl)naringenin (2) 
A second compound was obtained from fractions 2 and 3 of the 
ethanol extract of the Zambian propolis as an amorphous yellow solid 
(38.8 mg) from the ethanol extract. The mass spectrum gave an [M-H]- 
ion at 339.1240 (Calc for C20H19O5, 339.1233). The NMR spectra and a 
summary table are given in section S4 of the Supplementary Informa-
tion. Its proton spectrum was similar to that of compound 1 except for 
two aromatic doublets at δH 6.87 (2H, d, J = 8.6 Hz) and 7.31 (2H, d, J =
8.6 Hz) replacing the 5H aromatic multiplets in compound 1. The carbon 
signals were also identical except for the signals at 115.8 (2 × CH), 
128.0 (2 × CH) and 156.5 (C) replacing the carbon signals of the phenyl 
group in 1. Therefore, C-4′ must be substituted with a hydroxyl group. 
This was further confirmed by the difference of 16 mass units between 
compound 2 and compound 1. The correlations in its 2D NMR spectra 
were similar to those of compound 1 and correlations from the protons 
in ring B confirmed the –OH attachment to C-4′. The full chemical shift 
assignments (Table S6-1) were thus made from the 2D spectra and were 
confirmed by comparison with literature reports (Seo et al., 1997) and 
the structure was assigned as 6-(1,1-dimethylallyl)naringenin (Fig. 3). 
Compound 3 was obtained as a mixture, which, by comparing ring B 
protons in the NMR, can be estimated to be composed of 52.4% com-
pound 3 with 47.6% compound 2. The LC-MS analysis of TP-F4-(7–9) 
exhibited many pseudo-molecular ion peaks, with a major peak at m/z 
339.1246 (C20H19O5, 2.368 ppm). For the compound isolated the IR 
spectrum showed the presence of an OH group at 3225 cm−1, carbonyl 
Table 3 
NMR Spectroscopic Data (500 MHz, CDCl3) for compound 1.  





2 5.37 (1H, dd, 5.8, 1.0) 78.7 (CH) H-3 C-1′, C-2′, C-6′
3 2.85 (1H, dd, 17.1, 3.1) 3.10 






4 – 196.0 (C) – – 
5 – 163.4 (C) – – 
6 – 111.7 (C) – – 
7 – 164.6 (C) – – 
8 5.99 (1H, s) 96.8 (CH) – C-6, C-7, C-9, 
C-10 
9 – 160.8 (C) – – 
10 – 103.1 (C) – – 
1′ – 138.5 (C) – – 
2′ 7.46 (1H, d, 1.1) 126.1 
(CH) 
H-3′ C-2, C-4′, C-6′
3′ 7.45 (1H, m) 128.8 
(CH) 
H-2′ C-1′
4′ 7.42 (1H, m) 128.8 
(CH)  
C-2′, C-6′
5′ 7.45 (1H, m) 128.8 
(CH)  
C-1′
6′ 7.47 (1H, d, 2.7) 126.1 
(CH)  
C-2, C-2′, C-4′
1′′ – 40.7 (C)  – 
2′′ 6.47 (1H, dd, 17.8, 10.5) 149.7 
(CH) 
H-3′′ C-1′′ , C-4′′, C- 
5′′




H-2′′ C-1′′ , C-2′′
4′′ 1.62 (s) 27.3 
(CH3) 
– C-1′′ , C-2′′, C- 
6 
5′′ 1.60 (s) 26.6 
(CH3) 
– C-1′′ , C-2′′, C- 
6 
5-OH 13.13 (s) – – C-5, C-6, C-10 
7-OH 7.50 (s) – – C-6, C-7, C-8  
Fig. 2. Compound 1, 6-(1,1-dimethyl allyl)pinocembrin.  
Fig. 3. Structure of compound 2, 6-(1,1-dimethylallynaringenin. Character-
ization of 5-hydroxy-4′′,4′′-dimethyl-5′′-methyl-5′′-H-dihydrofurano [2′′,3′′,6,7] 
flavanone (3). 
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group (1700, 1650 cm−1) and 1650, 1500 cm−1 for the presence of ar-
omatic rings. The proton spectrum of the fraction was similar to the one 
for compounds 1 and 2, the major difference between the spectra was 
the absence of the isopentyl side chain. The NMR spectra are shown in 
section S5 and summarized in Table 4. This was replaced by a saturated 
furan ring fused to ring A of the flavanone at positions C-6 and C-7. The 
oxymethine furan proton was observed at δH 4.46 ppm while the three 
methyl groups on the furan ring were at 1.18, 1.43 and 1.36 ppm. The 
carbon spectrum (Dept-q) showed 20 carbon signals with three methyls, 
two oxygenated methines, one methylene, one carbonyl and 12 aromatic 
carbons. The structure was confirmed using correlations in its 2D spectra 
as follows; the furan proton (H-2′′) showed 3J correlations to C-6 and C-7 
in the HMBC spectrum thus confirming the furan ring being fused at 
those positions. Similar correlations for the 5-OH indicated C-6 to be a 
quaternary carbon, hence further confirming the furan ring being fused 
at C-6 and C-7. The signals for the H-3 protons were observed at δ 2.73 
(1H, dt, J = 16.8, 4.2, H-3a) and 3.19 (1H, dd, J = 17.0, 13.1, H-3b) and 
were coupled to each other in COSY. Furthermore, the signal of the 
vicinal methyl protons was observed at δH 1.43 (3H, d, J = 7.0, H-3′′) 
and was coupled to H-2” in the COSY spectrum (Fig. S8-4). Its chemical 
shift values were fully assigned as given in Table 4. The structure was an 
assigned as the novel compound 5-Hydroxy-4′′,4′′-dimethyl-5′′-methyl- 
5′′-H-dihydrofurano [2′′,3′′,6,7]flavanone (Fig. 4). The proton and car-
bon spectra were similar to those obtained by Seo et al. where the 
compound they isolated differs from compound 3 in that the B ring is 
substituted with hydroxyl at position C-4 (Seo et al., 1997). Thus the 
carbon shifts obtained for compound 3 in rings A, C and the furan ring 
were similar to those in their compound but the carbon signals in ring B 
were generally at lower shift values. In the proton spectrum there was an 
obvious envelope for the aromatic protons at δH 6.90 ppm. The MS2 
spectrum was consistent with the proposed structure and is shown in 
figure S5-6 along with a proposed fragmentation scheme in Fig. S5-7. 
3.4. Activity of the isolated compounds against Trypanosoma 
species 
The isolated compounds were also tested on the same drug sensitive 
and multi-drug resistant clones of T. b. brucei and T. congolense. The 
results are presented in Table 5. Compound 2 from Zambian propolis 
displayed the highest activity against T. b. brucei, with an EC50 value of 
2.24 μg/mL. Compounds 3 þ 2 and 1 also displayed activity below 5 μg/ 
mL, with EC50 values of 3.02 and 4.01 μg/mL, respectively. The EC50 
Table 4 
NMR Spectroscopic Data (500 MHz, Acetone-d6) for compound 3.  






2 5.43 (1H, dd, J =
13.0,3.0) 
79.8 (CH) H-3b C-3 
3 2.73(1H, dt, J = 16.8, 4.2) 
3.19 (1H, dd, J =
17.0,13.1) 
43.3 (CH2) H-3a- H-3b 
H-2 
C-2, C-4 
4 – 197.1 (C) – – 
5 – 103.3 (C) – – 
6 – 114.3 (C) – – 
7 – 163.6 (C) – – 
8 5.89 (1H, s) 90.9 (CH) – C-6, C-10 
1′ – 129.7 (C) – – 
2′ 7.39 (1H, dd, J = 8.7, 2.8) 128.8 (CH) H-3′ C-2, C-6′
3′ 6.90 (1H, m) 115.9 (CH) H-2′ C-1′, C-5′
4′ 6.90 (1H, m) 115.9 (CH)  C-2′, C-3′ , 
C-5, C-6′
5′ 6.90 (1H, m) 115.9 (CH) H-6′ C-1′ C-3′
6′ 7.39 (1H, dd, J = 8.7, 2.8) 128.8 (CH) H-5′ C-2, C-2′
1′′ – 42.5 (C) – – 
2′′ 4.46 (1H, q, J = 6.5) 91.4 (CH) H-3′′
3′′ 1.36 (3H, d, J = 7.0) 25.3 (CH3) H-2′′ C-1′′ , C-2′′
4′′ 1.43 (3H, s) 14.2 (CH3)  C-1′′ , C-2′′, 
C-6 
5′′ 1.18 (3H, s) 20.7 (CH3)  C-1′′ , C-2′′
C-4′′ , C-6 
5-OH 12.45 (s) 96.5 (C)  C-6, C-9, 
C-10  
Fig. 4. The structure of 5-hydroxy-4′′,4′′-dimethyl-5′′-methyl-5′′-H-dihydrofur-
ano [2′′,3′′,6,7] flavanone (3). 
Table 5 
EC50 values of purified compounds isolated from ZP and TP propolis samples 
against T. brucei (n = 3).  
Purified 
Compounds 










































– 1.20 0.17 






The EC50 values are the average and SEM of at least 3 independent de-
terminations. RF = Resistance factor, being EC50(WT)/EC50(B48). Statistical 
significance was determined using an unpaired two-tailed Student’s t-test 
comparing the EC50 values of the resistant strain with those obtained for the 
control strain s427. 
Table 6 
EC50 values of purified compounds isolated from ZP and TP propolis samples on 













































– 0.94 0.6383 





The EC50 values are the average and SEM of at least 3 independent de-
terminations. RF= Resistance factor, being EC50(WT)/EC50(6C3). Statistical 
significance was determined using an unpaired two-tailed Student’s t-test 
comparing the EC50 values of the resistant strain with those obtained for the 
control strain Il3000. 
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values for the multidrug resistant strain B48 were within 1–1.2-fold (P >
0.05), thus the compounds were not cross-resistant with first-line HAT 
treatments pentamidine and melarsoprol (Bridges et al., 2007). The RF 
for pentamidine, included as control, was 144 (P = 0.0003; Table 5). 
Like the fractions tested above, the purified compounds displayed 
somewhat less potent activity against T. congolense than against T. brucei 
under the assay conditions, with EC50 values of 7.35, 10.47 and 13.77 
μg/mL for compounds 2, 1, and 3 þ 2, respectively. Again, no 
cross-resistance was observed with the main AAT treatment, diminazene 
aceturate (RF~1; P > 0.05; compare RF = 9.8 for diminazene) (see 
Table 6). 
The purified compounds and the most active fractions that were 
isolated from the Tanzanian and Zambian propolis samples were tested 
in vitro on the human cell line U937 and a murine cell line, RAW 246.7, 
using the resazurin assay. The results showed very low levels of toxicity, 
with similar EC50 values for both cell lines (Table 7). As the fractions and 
isolated compounds were more active against T. b. brucei than against 
T. congolense, the Selectivity Index (SI), being the ratio of the mamma-
lian cell line EC50 and the parasite cell line EC50, was higher for T. b. 
brucei, with values for the isolated compounds, between 15 and 70, 
compared to 7 up to 17 for T. congolense. Interestingly, as the crude 
fractions displayed both higher trypanocidal activity and lower toxicity, 
the SI values for the fractions were much higher, e.g. >100 for Tanza-
nian crude propolis relative to both Trypanosoma species (Table 7). 
4. Conclusion 
This study identified and characterized two novel flavanones isolated 
from Tanzanian and Zambian propolis samples. Both flavanones 
demonstrated antitrypanosomal activity against drug-susceptible and 
drug-resistant T. b. brucei and T. congolense. Interestingly, the Tanzanian 
propolis extract was found to have greater antitrypanosomal activity 
than its fractions and isolated compounds. EC50 values for this crude 
extract vs. T. b. brucei and T. congolense were 1.2 μg/mL and 1.46 μg/mL, 
respectively, with similar values against pentamidine-resistant T. b. 
brucei (EC50 1.02 μg/mL) and diminazene-resistant T. congolense (EC50 
1.62 μg/mL). These findings are in line with previous reports of greater 
antitrypanosomal activity of crude propolis extracts from Nigeria and 
Libya compared with their isolated phytochemicals (Siheri et al., 2014, 
2016); Omar et al., 2017). Taken together, these results consistently 
point to the possibility of a synergistic effect of the isolated compounds, 
although additive effects of multiple active compounds in the same 
extract cannot be excluded. These observations make the prospect of a 
more complex propolis extract, which would be decidedly cheaper to 
produce if it can be standardized, seem quite appealing, especially as the 
most active fractions displayed a very good Selectivity Index. 
Propolis, whatever its origin, appears to always exhibit high levels of 
anti-trypanosomatid activity, particularly exhibited by flavonoids 
(Alotaibi et al., 2019; Omar et al., 2016; Siheri et al., 2016). This is 
believed to be a self-selecting feature due to the bee’s vulnerability to 
certain trypanosomatid parasites. The Scottish honey bee microbiome 
contains high levels of genetic material derived from the trypanoso-
matid Lotmarim passim (Regan et al., 2018) and this organism has been 
found to be widespread in other bee populations (Castelli et al., 2019; 
Ravoet et al., 2015; Schwarz et al., 2015). Thus far there is no evidence 
that bees ingest propolis but since the spread of the protozoal infection 
occurs via insect feces (Ruiz-González and Brown, 2006), coating the 
surfaces in the hive with propolis that is active against trypanosomatids 
could prevent transmission. Interestingly, it has recently been reported 
that feeding propolis to bees also reduces infection with the micro-
sporidium bee parasite Nosema ceranae (Mura et al., 2020). In addition, 
it has been observed that propolis has beneficial effects in stabilising the 
honey bee microbiome (Saelao et al., 2020). We conclude that East Af-
rican propolis, like propolis from other African locations, has promising 
anti-kinetoplastid properties. 
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